Will the recent EU ruling on CRISPR stifle innovation in food & ag?
The recent decision by the European Court of Justice to treat the genome editing technique CRISPR-Cas as a form of genetic modification with strict rules has resulted in cancelled research projects and companies relocating some their R&D outside of Europe, according to an article in Resource magazine, a publication of Wageningen University & Research (WUR), Wageningen, Netherlands.